ABT 239
| CAS No. | 460746-46-7 | Cat. No. | BCP02168 |
| Name | ABT 239 | ||
| Synonyms | ABT-239;ABT239;460748-71-4(ABT 239 tartrate); | ||
| Formula | C22H22N2O.C4H6O6 | M. Wt | 480.51 |
| Description | ABT-239 is an H3-receptor inverse agonist developed by Abbott. It has stimulant and nootropic effects, and has been investigated as a treatment for ADHD, Alzheimer's disease, and schizophrenia. ABT-239 is more active at the human H3 receptor than comparable agents such as thioperamide, ciproxifan, and cipralisant. | ||
| Pathways | Ion Channel/Membrane Transporter Neuro Signaling Pathway GPCR/G Protein | ||
| Targets | Histamine Receptor TRP Channel | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.